Product Claims Reviewed Against Every Market That Matters

Taama reviews on-pack claims, marketing copy, and nutrition claims against each market's regulatory framework — returning a risk-scored assessment with regulatory source citations in minutes.

Book a Demo

See How it Works

Book a Demo

See How it Works

Product Claims Reviewed Against Every Market That Matters

Taama reviews on-pack claims, marketing copy, and nutrition claims against each market's regulatory framework — returning a risk-scored assessment with regulatory source citations in minutes.

Book a Demo

See How it Works

One Wrong Claim Can Stall Your Entire Launch

Teams that review product claims manually or market-by-market routinely approve language that is permitted in one jurisdiction but flagged as high-risk in another — FDA structure/function rules, TGA therapeutic claim thresholds, HSA's permitted claims list, and EC 1924/2006 each impose different standards on the same phrase. When a non-compliant claim reaches print, a retailer listing, or an ad network, the consequences range from rejection and reformatting costs to warning letters and delistings. Taama reviews every claim against each target market's framework simultaneously, returning a risk-scored assessment traced to the exact regulation, threshold, or policy — not an opinion.

One Wrong Claim Can Stall Your Entire Launch

Regulatory Confidence Scoring

Every Claim Evaluated Per Market

Each individual product claim, nutrition claim, or function claim in your marketing copy or on-pack text is assessed against the specific regulatory framework of every target market — including FDA structure/function rules, TGA therapeutic claims, HSA permitted claims, EC 1924/2006 authorized health claims, and market-specific frameworks across APAC, EU, and GCC. One upload returns a risk-scored assessment per claim per market.

Multi-market assessment from a single upload

Risk-scored assessment per claim per market

Covers FDA, TGA, HSA, EFSA and more

Risk-Based Classification

Confidence Score With Regulatory Source

Every claims assessment includes a confidence score alongside the underlying regulatory reasoning and the source documents that support it. Regulatory affairs teams and marketing compliance leads can see exactly why a claim was flagged, which document controls it, and what would be required to bring it into compliance — no interpretation required.

Regulatory reasoning visible at claim level

Source documents attached to each finding

Confidence score on every assessment

Product Claims Compliance & Assessment

Red Amber Green Risk Scoring Per Claim

Not all claims carry the same risk. Taama assigns a red, amber, or green risk score to every claim per market — red for claims that cross into prohibited or drug-claim territory, amber for claims that carry regulatory risk or require substantiation, green for claims that are clear to use. This scoring allows regulatory and marketing teams to prioritise remediation before copy is locked.

Risk level guides remediation priority

Drug-claim territory flagged as high risk

Red amber green risk score per claim

marketing-copy-ecommerce-review

Marketing Copy and Listings Reviewed

Product claim risk does not stop at the label. Taama reviews marketing copy, e-commerce product listings, and advertising content against the permitted claim frameworks of each target market — surfacing language that would be acceptable in one channel but rejected by a regulator, ad network, or retailer policy in another.

E-commerce and ad copy assessed

Same framework applied across all content types

Retailer and ad network policy coverage

Common questions from regulatory and brand teams evaluating Taama's label compliance check capability.

Food Supplement Label Compliance Questions Answered

Taama covers 12 live markets simultaneously, including the US (FDA structure/function and DSHEA), Australia (TGA therapeutic claims and FSANZ), Singapore (HSA permitted claims list), the EU (EC 1924/2006 authorized health claims and EFSA), the UK (FSA and MHRA), Canada (Health Canada NHP), Indonesia (BPOM), Malaysia (NPRA), Philippines (FDA PH), GCC (SFDA and ESMA), and Mexico (COFEPRIS). Every assessment is traced to the exact regulation or policy that governs the claim in that market.

Taama assigns a red, amber, or green risk score to every claim per market. Red flags claims that cross into prohibited or drug-claim territory and require removal or rewriting before the product can be marketed in that jurisdiction. Amber flags claims that carry regulatory risk or require substantiation documentation to proceed. Green confirms claims that are clear to use as written. Every assessment includes the regulatory source and reasoning behind the score, so teams know exactly what the risk is and what action to take.

From upload to assessment, Taama returns risk-scored results in minutes. All target markets are assessed in parallel — not sequentially — so a product targeting five markets returns five complete claims assessments simultaneously. The full multi-market product claims review runs within a single working session from upload to actionable output.

Yes. In addition to on-pack product claims, nutrition claims, and functional claims, Taama reviews marketing copy, e-commerce product descriptions, and advertising content against the permitted claim frameworks of each target market. The same regulatory standards that govern label claims apply to off-label marketing channels in most jurisdictions, and Taama applies consistent rules across both surfaces.

All Taama plans are custom-scoped based on your target markets, product catalogue size, and team requirements. There are no fixed tiers. This means you pay for the market coverage and catalogue scale that reflects your actual compliance footprint rather than a generic plan that may over- or under-serve your needs. Contact Taama directly to receive a scoped quote based on your specific situation.

Common questions from regulatory and brand teams evaluating Taama's label compliance check capability.

Whether you’re navigating TGA and FSANZ in ANZ, HSA in Singapore, BPOM in Indonesia, NPRA in Malaysia, EFSA in Europe, or FDA in the US, Taama runs the checks.

Validate Your Claims Before Copy Is Locked

See how Taama reviews your product and nutrition claims against every target market in minutes. Book a demo to walk through a live assessment on your products.

Book a Demo

Whether you’re navigating TGA and FSANZ in ANZ, HSA in Singapore, BPOM in Indonesia, NPRA in Malaysia, EFSA in Europe, or FDA in the US, Taama runs the checks.